Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideELVElevance Health
FinDog View：Neutral
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | ELV | JNJ |
|---|
| Close | 420.07 | 273.20 |
| Market Cap | $90.8B | $666B |
| 1M | +8.04% | +3.20% |
| P/E (TTM) | 17.9 | 41.3 |
| Forward P/E | 14.0 | 22.0 |
| P/E 5-Yr Percentile | 66 | 100 |
| P/S | 0.5 | 6.7 |
| P/B | 2.1 | 7.8 |
| Dividend Yield | 1.24% | 3.12% |
| Latest Quarter Revenue | $51.4B | $25.4B |
| Revenue YoY | +1.4% | +5.9% |
| Gross Margin | 89.0% | 68.1% |
| Latest Quarter EPS | 6.27 | 0.09 |
| Avg Post-Earnings Move | ±3.8% | ±0.6% |
| EPS Beat Rate | — | 1 / 1 |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 4.03% | 1.18% |
| 90-Day Net Insider Buying | −$4.7M | −$62.0M |
ELV · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
